255 related articles for article (PubMed ID: 22740397)
1. Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.
Shakirzyanova M; Tsai L; Ren W; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2012 Sep; 86(17):9432-42. PubMed ID: 22740397
[TBL] [Abstract][Full Text] [Related]
2. Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.
Ren W; Mumbauer A; Zhuang K; Harbison C; Knight H; Westmoreland S; Gettie A; Blanchard J; Cheng-Mayer C
Retrovirology; 2013 Jan; 10():9. PubMed ID: 23369442
[TBL] [Abstract][Full Text] [Related]
3. Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.
Zhuang K; Finzi A; Toma J; Frantzell A; Huang W; Sodroski J; Cheng-Mayer C
Retrovirology; 2012 Dec; 9():106. PubMed ID: 23237529
[TBL] [Abstract][Full Text] [Related]
4. Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.
Mumbauer A; Gettie A; Blanchard J; Cheng-Mayer C
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):496-504. PubMed ID: 23221980
[TBL] [Abstract][Full Text] [Related]
5. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
6. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
[TBL] [Abstract][Full Text] [Related]
7. Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.
Ren W; Mumbauer A; Gettie A; Seaman MS; Russell-Lodrigue K; Blanchard J; Westmoreland S; Cheng-Mayer C
J Virol; 2013 Jun; 87(11):6137-49. PubMed ID: 23514895
[TBL] [Abstract][Full Text] [Related]
8. CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV).
Chen Z; Zhao X; Huang Y; Gettie A; Ba L; Blanchard J; Ho DD
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):133-45. PubMed ID: 12045675
[TBL] [Abstract][Full Text] [Related]
9. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).
Harouse JM; Gettie A; Eshetu T; Tan RC; Bohm R; Blanchard J; Baskin G; Cheng-Mayer C
J Virol; 2001 Feb; 75(4):1990-5. PubMed ID: 11160699
[TBL] [Abstract][Full Text] [Related]
10. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
[TBL] [Abstract][Full Text] [Related]
11. The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection.
Tsai L; Tasovski I; Leda AR; Chin MP; Cheng-Mayer C
Retrovirology; 2014 Mar; 11():22. PubMed ID: 24612462
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
[TBL] [Abstract][Full Text] [Related]
13. Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research.
Bauer AM; Ziani W; Lindemuth E; Kuri-Cervantes L; Li H; Lee FH; Watkins M; Ding W; Xu H; Veazey R; Bar KJ
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969435
[TBL] [Abstract][Full Text] [Related]
14. Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.
Chenine AL; Siddappa NB; Kramer VG; Sciaranghella G; Rasmussen RA; Lee SJ; Santosuosso M; Poznansky MC; Velu V; Amara RR; Souder C; Anderson DC; Villinger F; Else JG; Novembre FJ; Strobert E; O'Neil SP; Secor WE; Ruprecht RM
J Infect Dis; 2010 Apr; 201(8):1155-63. PubMed ID: 20214475
[TBL] [Abstract][Full Text] [Related]
15. Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.
Ren W; Tasca S; Zhuang K; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2010 Jan; 84(1):340-51. PubMed ID: 19846515
[TBL] [Abstract][Full Text] [Related]
16. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.
Miller CJ; Marthas M; Greenier J; Lu D; Dailey PJ; Lu Y
J Virol; 1998 Apr; 72(4):3248-58. PubMed ID: 9525652
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.
Pal R; Taylor B; Foulke JS; Woodward R; Merges M; Praschunus R; Gibson A; Reitz M
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):300-7. PubMed ID: 12843740
[TBL] [Abstract][Full Text] [Related]
19. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
[TBL] [Abstract][Full Text] [Related]
20. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
